相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Three-Dimensional Primary Cell Culture: A Novel Preclinical Model for Pancreatic Neuroendocrine Tumors
Simon Leonhard April-Monn et al.
NEUROENDOCRINOLOGY (2021)
Models of Gastroenteropancreatic Neuroendocrine Neoplasms: Current Status and Future Directions
Katharina Detjen et al.
NEUROENDOCRINOLOGY (2021)
Soluble TIM3 and Its Ligands Galectin-9 and CEACAM1 Are in Disequilibrium During Alcohol-Related Liver Disease and Promote Impairment of Anti-bacterial Immunity
Antonio Riva et al.
FRONTIERS IN PHYSIOLOGY (2021)
The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancer
Sebastian Meltzer et al.
BRITISH JOURNAL OF CANCER (2021)
Ex Vivo Modeling of Human Neuroendocrine Tumors in Tissue Surrogates
Brendon Herring et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis
Alberto Bongiovanni et al.
PHARMACEUTICALS (2021)
Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patients
Devayani Machiraju et al.
ONCOIMMUNOLOGY (2021)
The 2019 WHO classification of tumours of the digestive system
Iris D. Nagtegaal et al.
HISTOPATHOLOGY (2020)
Perturbations in Mitochondrial Dynamics Are Closely Involved in the Progression of Alcoholic Liver Disease
Elena Palma et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2020)
Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study
Manuela Tiako Meyo et al.
CANCERS (2020)
Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma
Minh Phuong Dong et al.
SCIENTIFIC REPORTS (2020)
Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up y
M. Pavel et al.
ANNALS OF ONCOLOGY (2020)
Landscape and Future Perspectives of Immunotherapy in Neuroendocrine Neoplasia
Ilaria Maggio et al.
CANCERS (2020)
Neuroendocrine liver metastases: a contemporary review of treatment strategies
Jordan M. Cloyd et al.
HEPATOBILIARY SURGERY AND NUTRITION (2020)
Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesicles
Jacob J. Orme et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
An Organoid Biobank of Neuroendocrine Neoplasms Enables Genotype-Phenotype Mapping
Kenta Kawasaki et al.
CELL (2020)
Ex vivo organotypic culture system of precision-cut slices of human pancreatic ductal adenocarcinoma
Sougat Misra et al.
SCIENTIFIC REPORTS (2019)
Circulating biomarkers predictive of tumor response to cancer immunotherapy
Ernest Y. Lee et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2019)
H-STS, L-STS and KRJ-I are not authentic GEPNET cell lines
Tobias Hofving et al.
NATURE GENETICS (2019)
Ex vivo tissue slice culture system to measure drug-response rates of hepatic metastatic colorectal cancer
Steve Z. Martin et al.
BMC CANCER (2019)
Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: a UK nationwide cohort study 2013-2015
Tracey S. E. Genus et al.
BRITISH JOURNAL OF CANCER (2019)
Paget's Seed and Soil Theory of Cancer Metastasis: An Idea Whose Time has Come
Mohammed Akhtar et al.
ADVANCES IN ANATOMIC PATHOLOGY (2019)
The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines
Tobias Hofving et al.
ENDOCRINE-RELATED CANCER (2018)
Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors
Dirk Walter et al.
SCIENTIFIC REPORTS (2018)
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
L. Horn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
1308OActivity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx)
J C Yao et al.
ANNALS OF ONCOLOGY (2018)
Soluble immune checkpoints in cancer: production, function and biological significance
Daqian Gu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes
Aric . Colunga et al.
CLINICAL CANCER RESEARCH (2018)
Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment
Xu-Feng Zhang et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2017)
Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade
Jun Zhou et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Tumor slice culture system to assess drug response of primary breast cancer
Kishan A. T. Naipal et al.
BMC CANCER (2016)
Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell and patient-derived tumor organoids
Ling Huang et al.
CANCER RESEARCH (2016)
The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs
Seung Tae Kim et al.
JOURNAL OF CANCER (2016)
Pancreatic Neuroendocrine Tumors in Mice Deficient in Proglucagon-Derived Peptides
Yuko Takano et al.
PLOS ONE (2015)
Reconstructed Adeno-Associated Virus with the Extracellular Domain of Murine PD-1 Induces Antitumor Immunity
Osama A. O. Elhag et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
John K. Ramage et al.
GUT (2012)
The Role of Cell Lines in the Study of Neuroendocrine Tumors
Simona Grozinsky-Glasberg et al.
NEUROENDOCRINOLOGY (2012)
A Multimodal Approach to the Management of Neuroendocrine Tumour Liver Metastases
Ron Basuroy et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2012)
Ki-67 index, tumor differentiation, and extent of liver involvement are independent prognostic factors in patients with liver metastases of digestive endocrine carcinomas
O. Hentic et al.
ENDOCRINE-RELATED CANCER (2011)
Enhancement of Vaccine-induced Primary and Memory CD8+ T-cell Responses by Soluble PD-1
Mi-Young Song et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Varying Opinions on the Authenticity of a Human Midgut Carcinoid Cell Line - Letter
Lee M. Ellis et al.
CLINICAL CANCER RESEARCH (2010)
Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies
Inge A. M. de Graaf et al.
NATURE PROTOCOLS (2010)
T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases
Steven C. Katz et al.
HPB (2010)
The CM cell line derived from liver metastasis of malignant human insulinoma is not a valid beta cell model for in vitro studies
Claudia Gragnoli
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors
Irvin M. Modlin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
The development and characterization of a human midgut carcinoid cell line
George Van Buren et al.
CLINICAL CANCER RESEARCH (2007)
A transgenic mouse model of metastatic carcinoma. involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotype
AJ Syder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
分享论文
